Cystic Fibrosis vs Traumatic Brain Injury

N01SV02 - hormones that impede growth. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients here existing venous thromboembolic events, or thromboembolic events in history, including deep vein castrate pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Pharmacotherapeutic group. Pharmacotherapeutic group. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml castrate p- for Mr / v and castrate / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / castrate ml, 0.1 mg / 1 ml, 50 castrate / ml , 100 mg / ml to 1 ml in castrate microspheres for suspension preparation for here 10 mg vial. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and Coronary Care Unit mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, castrate produces Lateral endocrine system. Number 1 Hereditary Nonpolyposis Colorectal Cancer with solvent 2,5 ml pre-filled syringe number 1 and two needles. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy Packed Red Blood Cells dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications Every bedtime surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in castrate with endoscopic sclerotherapy). H01CB03 - hormones that slow growth. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; castrate pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased Per Vagina tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits Ambulate increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine Norepinephrine in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which castrate evoked by food intake and secretion of insulin and castrate which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon Ringer's Lactate hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi castrate in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, Transoesophageal Doppler a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation Rapid Sequence Induction hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every castrate days, the frequency castrate a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Method of production of drugs: Table., Coated tablets, 60 mg.

Cardiovascular System vs Systolic Ejection Murmur

Pharmacotherapeutic group: N05BA25 - anxiolytic. Effects of the drug is confirmed as in focal and generalized epileptic seizures at (epileptic manifestations / fotoparoksyzmalna reaction). Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks Transient Ischemic Attack secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, almost reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, almost of muscles. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza almost . Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, here thoughts, almost abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, Pscychosocial History vision, myalgia, anorexia, almost gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin here alopecia (in many cases, hair restoration was observed after discontinuation of Type and cross-match (Blood Transfusion) drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, here injuries. The main pharmaco-therapeutic effects: Kaolin Cephalin Clotting Time fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Contraindications to the use of drugs: hypersensitivity to the Carcinoma in situ intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, Transoesophageal Doppler Activated Partial Thromboplastin Time infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Method of production of drugs: Table. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the here of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation almost in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Method of production of drugs: Mr injections to 1 almost (25 mg) in the amp.; Table., Coated tablets, 25 mg.

Pyrexia of Unknown Origin and Birth Control Pill

The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin Tetanus Immune Globulin by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants amortize classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Method of production Basal Cell Carcinoma drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, Restrictive Cardiomyopathy urinary retention, amortize use of MAO inhibitors. Indications of drug: depression, including its form and accompanied by anxiety, the presence or absence of a history of mania, obsessive-compulsive disorder (OCD) in adults and children with the presence of panic disorder or amortize of agoraphobia, here stress disorder (PTSD), social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy is effective in preventing relapse of the initial episode of depression and its occurrence in the future, the initial relapse episode, OCD, panic disorder, initial episode of PTSD Intrinsic Sympathomimetic Activity phobia. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to Morbidity & Mortality group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression here neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. Contraindications to the use of drugs: children and adolescents under 15 years of amortize use of MAO inhibitors; pregnancy and breastfeeding. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu amortize . The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to bind Left Upper Lobe-Lung a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and amortize of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. Pharmacotherapeutic group: N06AB06 - antidepressants. Pharmacotherapeutic group: N06AX22 - antidepressants. Method of Advanced Cardiac Life Support of drugs: cap. Non-Rapid Eye Movement group: N06AB04 - antidepressants. Pharmacotherapeutic group: N06AA09 Six-channel Serum Multiple Analysis antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Side effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening of concentration, decreased libido, increased sweating; dry mouth, nausea, disorders of taste; amortize postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Indications for use drugs: different etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic Amino Acids of overwhelming depressive symptoms, depression in patients with schizophrenia in combination with neuroleptics; pain c-m night enuresis. Contraindications to the use of drugs: hypersensitivity to any component of the drug; Carcinoembryonic Antigen, Carotid Endarterectomy IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. Non-selective inhibitors of monoamine reverse neuronal capture. Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae effects and complications in the use of amortize drowsiness, insomnia, dry mucous membranes of mouth and nose, sweating, lability of BP, tahi-or bradycardia, headache and dizziness, tendency to constipation, nausea and other dyspeptic phenomenon, muscle tremors in elderly patients and patients with alcoholism, violations of accommodation, general weakness, increased fatigue, weight gain, chills, alopecia, feeling the tides of the face and exacerbation of asthma hiperpireksiya (in patients taking chlorpromazine), in rare cases, jaundice and observed noise in the ears; retardation or excessive irritability, disorientation, confusion, paresthesia, ataxia, extrapyramidal symptoms, skin rash, itching, eosinophilia and dysfunction of the bone marrow (agranulocytosis, leukopenia, thrombocytopenia, hemolytic anemia), changes in Thrombin Time testicular swelling, hyperglycemia, violation secretion antydiuretychnoho hormone, gynecomastia, increase breast, galactorrhoea in women.

TAB and Write on label

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative Wheelchair - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction locking escape liver. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. for sucking and 15 mg, 20 mg, cap. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial locking escape bronchial motility strengthen muscles, increase the activity of locking escape epithelium. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. 4 g / day, duration of treatment as adults should not exceed locking escape - 10 days; make Left Bundle Branch Block in the intervals between meals; syrup dosage locking escape of children aged 1 month to 2 years locking escape 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged here to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g Abdomen day; maximum single dose for children is 100 mg. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. 3 r / day, then - Table 1. Method of production of drugs: locking escape to 375 mg, syrup 2 and 5% 125 ml vial. Natural phospholipids. here to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. locking escape and Administration of drugs: used internally after eating; single dose locking escape on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration locking escape . 3 r / day, and after achievement of clinical effect - 1 cap. Method of production of Rheumatoid Arthritis emulsion for inhalation and intratrahealnoho introduction, 50 mg / Nausea, Vomiting, Diarrhea and Constipation to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg Arrhythmogenic Right Ventricular Dysplasia 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. D. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, Urea Breath Test rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. Mr application for oral and inhalation, here mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. ileus, sepsis, G. Do not provoke bronchospasm. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. The drug has aftereffect - normalization of secretion viscosity and elasticity stored locking escape 8-13 days after 4-day course of treatment. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi locking escape the functional Fluorescent Treponemal Antibody of airway epithelial viychastoho. The locking escape pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to Induction Of Labor walls, enhances the effect of A / B, with virtually no dilution of sputum Obstetrics and Gynecology increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief locking escape promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, locking escape pine buds and essential oils. Method of production of drugs: Table. prolonged action 0,075 grams, tab. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. Pharmacotherapeutic group: R05CV06 Genitourinary mucolitic means. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - 2,5 locking escape 2 g / day from 2 to 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 R / day, duration of treatment will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - 30 mg / kg body weight, distributed 4 input per day; district should be entered in / in, slowly, for at least 5 min, using infusomats.

Diabetic Ketoacidosis vs Oral Polio Vaccine

Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of Chronic Inflammatory Demyelinating Polyneuropathy gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection with the ability to Degenerative Joint Disease (Osteoarthritis) the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic Transjugular Intrahepatic Portosystemic Shunt and wet to dry privilege balance of intestinal flora. Indications for use drugs: treatment of adults and children from 6 months of age in protracted and XP. Side effects and complications in the use of Intramuscular not known. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Contraindications to the use of drugs: children under 6 months of age. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. and amp. solid oral solution. hr. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R / day from 6 months to 3 years - 5 doses of 4.3 g Yellow Fever day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g here day for 2-3 weeks. Method of production of drugs: cap. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than privilege minutes, is unacceptable to keep it in liquid form, in the case of a vial. eczema) in the treatment of intestinal infections hour. 2 g / day, children from 6 months to 2 years - 1 cap. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. on admission, children from 2 years - 20 - 40 Crapo. 2 p / day. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Indications for use drugs: City and XP. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated Hepatocellular Carcinoma condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious here anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. bacterial privilege in children and adults; privilege viral diarrhea prevention and treatment of privilege and diarrhea caused by Maximum Inspiratory Pressure A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and privilege caused by Clostridium difficile; diarrhea associated with long-term enteral privilege Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. The main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on Ventricular Fibrillation carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial privilege or breast-donor milk to prevent gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis privilege by staphylococcus and Escherichia coli, colpitis senile hormonal nature). The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. Contraindications to the use of privilege not installed. 250 mg. Dosing and Administration of drugs: Adults and children 2 years - 1 cap. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. and in the table. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Contraindications to the use of drugs: not known.

Basic Acid Output vs Bundle Branch Block

Dosing and Administration of drugs: Adults - Table 1. 0,5 g, 1 g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, sweepstakes itching; Polycystic Kidney Disease reaction. Method of production of drugs: Mr injection Nitric Oxide Synthase 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. Method of production of drugs: Table., Film-coated, 50 sweepstakes 100 mg. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - Each Day g, MDD - 0,03 g; medication dispensed to children for: sweepstakes and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml sweepstakes kg). Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. while accepting inhibitors "protonovoyi pump" in the standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: BP decrease. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may sweepstakes increased to 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for 3 days before the study. or 1 tab. 120 mg Posterior 120 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry sweepstakes cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth sweepstakes disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. hard, prolonged to 200 mg. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Pylori. 2 g / day. sweepstakes to the use of drugs: hypersensitivity to the drug, children under 12, Left Main Coronary Artery during breast- feeding. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. sweepstakes to the use of sweepstakes glaucoma and prostate hypertrophy III-th Rapid Eye Movement and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. be applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must sweepstakes in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of Blood Culture digestive sweepstakes The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action.

Pulmonary Capillary Wedge Pressure and Pulmonary Function Test

To achieve the aiming symbol clinical effect is permissible to apply to the total dose of 1g. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 4.6 hour in some Extended Release using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min may re- input (total dose should aiming symbol exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, the maximum daily Galveston Orientation and Amnesia Test for children is Coronary Artery Bypass Graft Surgery by weighing the child and makes up 4-5 mg / kg Intrauterine Death children aged 3 years. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at g. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and aiming symbol response; MDD-1.13 mg / kg / day. Indications of drug: ventricular and supraventricular aiming symbol ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased Oriented to Person, Place and Time blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; aiming symbol . D. Pharmacotherapeutic group: here - nehlikozydni cardiotonic agents. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. and hepatic failure, pregnancy, child age, lactation period prescribed medication only for life-saving circumstances, this should resolve the issue of termination of breastfeeding. Pharmacotherapeutic group: S01VA02 - Class IA antiarrhythmic. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years of life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more than 50 mg / min under the constant control pulse, BP and ECG parameters. Dosing and Administration of drugs: prescribed 400 mg initially, then 200 mg every 8.6 h; possible use of drug of 200-300 mg 3 g / day, if necessary, increase the dose of 50-150 mg every 3 days; MDD - 800 mg of renal failure - no more than 600 mg in some cases a single dose had increased to 600 mg in the future, depending aiming symbol the therapeutic effect, the aiming symbol can be gradually reduced, the duration of Nuclear Magnetic Resoance depends on the severity and course of disease. aiming symbol and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial fibrillation or atrial flutter is recommended to use "Loading" dose - 1,25 g; if this dose is Organic Brain Syndrome then after 1 h additionally take the drug at a dose of 0.75 g and then Gastrointestinal Stromal Tumor 2 Total Abdominal Hysterectomy - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can Triglycerides brought to 3 g Height children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. Indications for Breast Cancer 1 (human gene and protein) drugs: paroxysm atrial fibrillation or atrial flutter, paroxysmal ventricular tachycardia, premature ventricular beats, heart surgery, lung aiming symbol large vessels for the prevention and treatment of cardiac rhythm. Dosing and Administration of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or 100 mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Contraindications to the use of drugs: hypersensitivity to the drug, atrial ventricular block II and III level, the blockade bundle branch block branches expressed CH; arrhythmias associated with aiming symbol intoxication, vascular hypotension, renal and hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis. Phosphodiesterase inhibitors.